Board of Directors

John Fallone

Mr. Fallone brings to the Coldstream board successful entrepreneurial, executive and leadership experience in technically complex manufacturing operations gained largely in the pharmaceutical and process industries. He held various executive leadership positions in Sterling Drug, culminating as Division President of Sterling Organics where he oversaw Sterling's API internal and contract manufacturing operations in the US, Puerto Rico and the UK. He later became the Vice President of US Operations for NycomedAmersham, overseeing their US API, Injectable, Aerosols and Solid Dosage manufacturing operations serving both internal and contract based customers. In 1999 Mr. Fallone led a successful $60 Million management buyout of the Nycomed Amersham API facility in Rensselear NY forming the new contract manufacturing company Organichem. Under Mr. Fallone's leadership Organichem grew significantly, branching into high potency and controlled substance manufacturing and piloting/clinical supply process development.Organichem was ultimately successfully sold to an investor. Since Organichem, Mr. Fallone has continued to consult and invest in various entrepreneurial manufacturing businesses and is currently serving as the President and CEO of Electro Metrics, an antenna and RF equipment manufacturing company that largely serves the US government. Mr. Fallone graduated from Clarkson College of Technology in 1975 with a BS in Mechanical Engineering. Prior to Sterling Drug, Mr. Fallone also held various engineering positions with Shell Chemical Company and General Electric.

 tracy jim 1


James W. Tracy

Dr. James W. Tracy is the vice president for research at the University of Kentucky. In this role, he leads the university’s $368-million-a-year research enterprise and oversees a number of interdisciplinary research centers and institutes.

Tracy earned a PhD in biochemistry from the College of Agriculture at Purdue University in 1976. From 1978 to 1983, he was a postdoctoral scientist and research assistant professor in pharmacology and geographic (tropical) medicine at Case Western Reserve University School of Medicine.

In 1983 he moved to the University of Wisconsin–Madison as one of the founding faculty of the new School of Veterinary Medicine, where he rose through the academic ranks to full professor. He taught pharmacology in both the professional DVM and MD programs. He directed the graduate program in environmental toxicology for nearly a decade. His research, which was funded primarily by the National Institutes of Health, focused on chemotherapy for human and animal parasitic diseases and mechanisms of toxicant action. Tracy served for more than 10 years on NIH study sections and chaired the Tropical Medicine and Parasitology Study Section for three years.

In 2000 he became associate dean for research for the School of Veterinary Medicine and later led UW-Madison Select Agents Program, which is responsible for the use and storage of biological agents and toxins that have potential to be used in bioterrorism. He directed the Biotron Laboratory, a university research center that provides controlled research environments for plant, animal and materials research.

In conjunction with his move to UK in October 2007, Tracy retired from UW–Madison and was named professor emeritus.

He serves on the board of directors of the Council on Governmental Relations (COGR), an association of 183 research universities. COGR develops policies and practices that fairly reflect the mutual interests and separate obligations of federal agencies and universities in research and graduate education.


describe the image

Eric W. Smart

President & CEO, Coldstream Laboratories

Eric Smart has over 20 years of sales, sales management, marketing and project management in the pharmaceutical contract research and contract manufacturing industries. He held positions at AMRI, Organichem Corporation, AlliedSignal and Albemarle Corporation.

Mr. Smart was a co-founder of Organichem Corporation in 1999 and was a member of the management team that organized the management buyout that formed Organichem. As VP of Business Development he played a key role in realizing the company's financial milestones that led to a successful sale of the business to AMRI in 2002.

Mr. Smart holds a BS degree in chemistry from Vanderbilt University and an MBA from the University of Maryland. Prior to entering the pharmaceutical industry, Mr. Smart served eight years as an officer in the US Navy.

Frederick A. Sexton

Mr. Sexton brings to Coldstream's Board his experience as an innovative and entrepreneurial executive with over 29 years of broad industry experience and proven abilities in strategic planning, tactical execution, staff development and creation of team based environments. He has specific experience in developing and leading start-up companies to success, as well as streamlining and positioning mid to large international pharmaceutical companies for growth into the 21st century. He is the Founder and President of New World Pharmaceuticals, LLC, a privately held specialty pharmaceuticalcompany focused on the development of novel delivery and patient interface systems. Before starting New World Pharmaceuticals, Mr. Sexton spent over four years with Purdue Pharma L.P., ultimately becoming the Senior Vice President, Technical Operations and Non-Clinical R&D. Prior to Purdue Mr. Sexton was part of the start-up team of Kos Pharmaceuticals, Inc. where he was the Sr Vice President of Technical Operations and Product Development. In this capacity he helped build the company from its infancy through its IPO and into a successful fully integrated pharmaceutical company. In addition to his Purdue and Kos assignments he spent 12 years with Boehringer Ingelheim Pharmaceuticals in various management positions both domestically and internationally; and four years with Ayerst Laboratories in pre-clinical research and pilot plant management positions. Mr. Sexton is a former member of the Board of Directors of the International Society of Pharmaceutical Engineers (ISPE) and the ISPE International Leadership Forum. He was the Chair and chief editor of ISPE's Good Practice Guide for Technology Transfer. Mr. Sexton holds as BS from Clarkson College of Technology. He is a member of Clarkson University's School of Arts and Sciences Advisory Board. Mr. Sexton has multiple issued and pending formulation, drug delivery and device patents.

Timothy Tracy, Ph.D., R.Ph.
Dean, UK College of Pharmacy

Dr. Tim Tracy is a native of South Webster, Ohio. Dr. Tracy received his bachelor's degree in pharmacy from Ohio Northern University and began his career as a pharmacist in Gallipolis and Portsmouth, Ohio, before returning to school to receive his doctoral degree. He received his Ph.D. in clinical pharmacy from Purdue University, and completed a postdoctoral fellowship in clinical pharmacology at Indiana University.

Dr. Tracy began his academic career at West Virginia University where he served as a faculty member working his way from assistant professor to professor from 1992 to 2003. In 2003, he joined the faculty at the University of Minnesota as professor and was named department head in 2004. In 2010, Dr. Tracy was named Dean of the University of Kentucky College of Pharmacy. He started at UK in August 2010.

Dr. Tracy has garnered extramural funding through the National Institutes of Health and currently is the principal investigator on two NIH supported grants and co-investigator on a third project with total funding of more than $2.7 million. In addition, he is the author of numerous scientific publications, book chapters and two books. He also holds two patents. Dr. Tracy's area of research is drug metabolism and disposition.


describe the image Murray B. Clark, Jr.

Vice President for Health Affairs and Chief Financial Officer

UK HealthCare® / University of Kentucky

Murray B. Clark Jr., currently serves as vice president for health affairs and chief financial officer of the University of Kentucky’s branded health care system UK HealthCare.  The academic health system has 825 licensed beds, revenues in excess of $1 billion and encompasses  the medical, nursing, health sciences, public health, dental and pharmacy patient care activities of the University of Kentucky in Lexington, as well as several off-site locations. 

With more than 40 years of experience in health care financial management, Mr. Clark oversees all aspects of financial operations, revenue cycle and treasury, managed care contracting and decision support for UK HealthCare.  In addition, he is also responsible for strategic planning and decision support, facility planning and development, which includes leading the design, construction and operational planning for the new Chandler Hospital pavilion that opened in May 2011.

Since joining the University of Kentucky in 1980, he has held several positions in finance and served as the Chandler Hospital CFO for 19 years. Prior to joining the University of Kentucky, Mr. Clark held administrative positions at Woodford Memorial Hospital in Versailles, Ky., and Morgan County Appalachian Regional Hospital in West Liberty, Ky. 

He currently serves on the boards of directors for Kentucky Medical Services Foundation (KMSF), Central Kentucky Management Services (CKMS) and Coldstream Laboratories, Inc.

Mr. Clark earned an MBA from Xavier University in Cincinnati, Ohio, and a bachelor’s degree in business administration from Eastern Kentucky University.